Clinical trials are vital to improving treatments for any cancer, but are especially important for rare sarcomas. For instance, treatment advances through clinical studies have provided effective alternatives to amputation of a limb — previously a primary form of treatment for sarcomas.
Recent trials have examined minimizing side effects and maximizing outcomes for patients undergoing radiation therapy. Our sarcoma experts also focus on innovative medical therapies for patients who are experiencing recurrence. The Sarcoma Program participates in significant, multi-institutional studies through membership in such groups as the NRG Oncology, Sarcoma Alliance for Research Through Collaboration and the National Cancer Institute.